seed
Stage
1
Investors
About
TileBio develops AI pathology foundation models that self-learn a universal visual language of tissue from millions of unlabelled medical images to improve clinical diagnostics, biomarker discovery, and drug development.
Explore TileBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.